[HTML][HTML] Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases

AL Cardoso, A Fernandes, JA Aguilar-Pimentel… - Ageing research …, 2018 - Elsevier
Objective Use of the frailty index to measure an accumulation of deficits has been proven a
valuable method for identifying elderly people at risk for increased vulnerability, disease …

Application of ultrasound for muscle assessment in sarcopenia: towards standardized measurements

S Perkisas, S Baudry, J Bauer, D Beckwée… - European geriatric …, 2018 - Springer
Purpose Measurement of muscle mass is paramount in the screening and diagnosis of
sarcopenia. Besides muscle quantity however, also quality assessment is important …

Prediction of sarcopenia using a battery of circulating biomarkers

R Qaisar, A Karim, T Muhammad, I Shah, J Khan - Scientific reports, 2021 - nature.com
Loss of muscle mass and strength with aging, termed sarcopenia is accelerated in several
comorbidities including chronic heart failure (CHF) and chronic obstructive pulmonary …

Biomarkers for physical frailty and sarcopenia: state of the science and future developments

R Calvani, F Marini, M Cesari, M Tosato… - Journal of cachexia …, 2015 - Wiley Online Library
Physical frailty and sarcopenia are two common and largely overlapping geriatric conditions
upstream of the disabling cascade. The lack of a unique operational definition for physical …

Muscle quality in aging: a multi-dimensional approach to muscle functioning with applications for treatment

MS Fragala, AM Kenny, GA Kuchel - Sports medicine, 2015 - Springer
Aging is often accompanied by declines in physical functioning which impedes older adults'
quality of life, sense of independence, and ability to perform daily tasks. Age-related …

Lean mass abnormalities in heart failure: the role of sarcopenia, sarcopenic obesity, and cachexia

S Carbone, HE Billingsley… - Current problems in …, 2020 - Elsevier
The role of body composition in patients with heart failure (HF) has been receiving much
attention in the last few years. Particularly, reduced lean mass (LM), the best surrogate for …

Biochemical markers of musculoskeletal health and aging to be assessed in clinical trials of drugs aiming at the treatment of sarcopenia: consensus paper from an …

A Ladang, C Beaudart, JY Reginster… - Calcified Tissue …, 2023 - Springer
In clinical trials, biochemical markers provide useful information on the drug's mode of
action, therapeutic response and side effect monitoring and can act as surrogate endpoints …

[HTML][HTML] Intensive care unit-acquired weakness: a review of recent progress with a look toward the future

W Wang, C Xu, X Ma, X Zhang, P Xie - Frontiers in medicine, 2020 - frontiersin.org
Intensive care unit-acquired weakness (ICU-AW), a common neuromuscular complication
associated with patients in the ICU, is a type of skeletal muscle dysfunction that commonly …

A glitch in the matrix: the pivotal role for extracellular matrix remodeling during muscle hypertrophy

CR Brightwell, CM Latham… - … of Physiology-Cell …, 2022 - journals.physiology.org
Multinuclear muscle fibers are the most voluminous cells in skeletal muscle and the primary
drivers of growth in response to loading. Outside the muscle fiber, however, is a diversity of …

Sex differences in adaptations in muscle strength and size following resistance training in older adults: A systematic review and meta-analysis

MD Jones, MA Wewege, DA Hackett, JWL Keogh… - Sports Medicine, 2021 - Springer
Background Reductions in muscle size and strength occur with aging. These changes can
be mitigated by participation in resistance training. At present, it is unknown if sex …